Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Neuroimmunology|December 12, 2022
Myeloid cell heterogeneity in the tumor microenvironment and therapeutic implications for childhood central nervous system (CNS) tumorsSujay Kalathoor, Sakthi Rajendran, Alessandro Canella, et al.Journal of Materials Chemistry. B|December 18, 2018
Barcoding chemical modifications into nucleic acids improves drug stability in vivoCory D Sago, Sujay Kalathoor, Jordan P Fitzgerald, et al.Advanced Materials (Deerfield Beach, Fla.)|February 13, 2019
Nanoparticles Containing Oxidized Cholesterol Deliver mRNA to the Liver Microenvironment at Clinically Relevant DosesKalina Paunovska, Alejandro J Da Silva Sanchez, Cory D Sago, et al.Advanced Materials (Deerfield Beach, Fla.)|November 20, 2019
Mild Innate Immune Activation Overrides Efficient Nanoparticle-Mediated RNA DeliveryMelissa P Lokugamage, Zubao Gan, Chiara Zurla, et al.Nano Letters|March 1, 2018
A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak CorrelationKalina Paunovska, Cory D Sago, Christopher M Monaco, et al.Blood|August 2, 2022
Ventricular arrhythmias and sudden death events following acalabrutinib initiationSeema A Bhat, John Gambril, Leylah Azali, et al.Journal of Hematology & Oncology|July 14, 2022
Hypertension and incident cardiovascular events after next-generation BTKi therapy initiationSunnia T Chen, Leylah Azali, Lindsay Rosen, et al.Nature Biomedical Engineering|February 22, 2022
Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liverCory D Sago, Melissa P Lokugamage, David Loughrey, et al.JACC. Cardiooncology|November 16, 2023
Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: JACC: CardioOncology State-of-the-Art ReviewCooper Quartermaine, Sanam M Ghazi, Aneeq Yasin, et al.International Journal of Cancer|August 19, 2024
Representation of women in clinical trials supporting FDA-approval of contemporary cancer therapiesSujay Kalathoor, Sanam Ghazi, Beryl Otieno, et al.Pageof 1